Article info

QUALITY OF LIFE OUTCOMES FROM GOG 179: A PHASE III TRIAL OF CISPLATIN VS CISPLATIN/TOPOTECAN IN RECURRENT OR PERSISTENT CARCINOMA OF THE CERVIX

Authors

Citation

Monk BJ, Huang H, Cella D, et al
QUALITY OF LIFE OUTCOMES FROM GOG 179: A PHASE III TRIAL OF CISPLATIN VS CISPLATIN/TOPOTECAN IN RECURRENT OR PERSISTENT CARCINOMA OF THE CERVIX
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.